Loading patent…
AssigneesNovmetapharma Co., Ltd., Seoul National University Hospital, Seoul National University R&Db Foundation
InventorsHoe Yune Jung, Do Hyun Lee, Heon Jong Lee, Yon Su Kim, Seung Hee Yang
Estimating the term…
A cyclo(His-Pro)(CHP) is useful for preventing, alleviating or treating peritoneal fibrosis. A pharmaceutical composition for preventing or treating peritoneal fibrosis, a dietary supplement composition for preventing or alleviating peritoneal fibrosis, and a peritoneal dialysis solution, which all contain CHP is disclosed. Also disclosed are a method for preventing or treating peritoneal fibrosis by using CHP, a peritoneal dialysis method using CHP, a use of CHP during the preparation of a pharmaceutical composition for preventing or treating peritoneal fibrosis, and/or a use of CHP in the preparation of a peritoneal dialysis solution.
A method for preventing or treating peritoneal fibrosis in a subject in need thereof, comprising administering an effective amount of cyclo(His-Pro) or a pharmaceutically acceptable salt thereof to the subject.
A method for preventing or treating peritoneal fibrosis in a subject in need thereof, comprising administering an effective amount of a composition comprising cyclo(His-Pro) or a pharmaceutically acceptable salt thereof to the subject, wherein the peritoneal fibrosis is epithelial-mesenchymal transition (EMT)-induced peritoneal fibrosis.
Dependencies are inferred from the claim text.